Allergan agrees to acquire Vitae Pharmaceuticals
Allergen plc announced last week that it has reached an agreement to acquire Vitae Pharmaceuticals Inc. for $21 per share in cash. Read More »
Allergen plc announced last week that it has reached an agreement to acquire Vitae Pharmaceuticals Inc. for $21 per share in cash. Read More »
Valeant Pharmaceuticals International recently acquired the necessary lender approval for a credit facility amendment. Read More »
Foam Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company dedicated to the development and commercialization of topical foams to fill unmet dermatology needs, will be releasing the results of its Phase 2 FMX103 clinical trial on Sept. 12. Read More »
Antibiotic agent treats severe drug-resistant bacterial skin and skin structure infections. Read More »
The reason for the recall are two complaints from customers in the United Kingdom and Portugal that involve the detachment of needles from the syringe with SWFI, or Sterile Water for Injection. Read More »
Patent-protected Alzheimer's medication subject of infringement litigation. Read More »
Genmab recently announced that its data from the Phase III CASTOR study of daratumumab, which was presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting and at the 21st Congress of the European Hematology Association (EHA), has been published by the New England Journal of Medicine. Read More »
Men who received placebo and subsequent treatment with fexapotide show lower surgery rates. Read More »
Second trial of cariprazine in treatment of MDD did not show significant changes versus placebo. Read More »
Asembia LLC, an industry leader in specialty pharmacy management company, recently unveiled its new HUB service and patient support program, which was developed as part of a partnership with MannKind Corp. and is designed for Afrezza Inhalation Powder. Read More »
The U.S. Food and Drug Administration (FDA) recently approved Merck’s anti-PD-1 therapy, KEYTRUDA, for use in fixed doses of 200 mg on a tri-weekly basis for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients. Read More »
Board increases to 12 members; 11 are independent directors. Read More »
Allergan recently announced that it has surpassed its goal of donating $1 million worth of REFRESH eye drops to first responders around the country. Read More »
Award-winning chef teams with pharmaceutical companies and dermatology organizations in the 'Understand AD' campaign. Read More »
Titratable fixed-ratio combination found superior to lixisenatide and insulin glargine. Read More »
Teligent Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted approvals for its abbreviated new drug applications (ANDAs) for Triamcinolone Acetonide Lotion USP, 0.1 percent and Triamcinolone Acetonide Lotion USP, 0.025 percent. Read More »
Seasoned executive joins Amarin senior management team. Read More »
BELKYRA received a positive opinion by the Swedish Medical Products Agency. Read More »
Allergan plc, the worldwide medical aesthetics company that designed Juvederm facial fillers, recently published “The Changing Faces of Beauty: A Global Report” to show that women have discovered new attitudes toward beauty and their pursuit of it. Read More »
Antibiotic developed to treat gram-negative bacterial infections; uses a combination of ceftazidime and avibactam. Read More »